Parameter Students (n [%]) Criteria and
P-value
Fourth-year
(n = 48) 		Fifth-year
(n = 59)
In which cases bisphosphonates can be prescribed
For patients with osteoporosis 43 (89.6%) 47 (79.7%) χ² = 1.95, P = 0.163
For patients with Paget's disease 23 (47.9%) 33 (55.9%) χ² = 0.682, P = 0.409
For metastases in bones 23 (47.9%) 32 (54.2%) χ² = 0.423, P = 0.515
For gastrointestinal tract metastases 15 (31.3%) 11 (18.6%) χ² = 2.286, P = 0.31
Correct answers about bisphosphonates properties
Bisphosphonates that are taken only orally 3 (6.3%) 0 (0%) χ² = 3.794, P = 0.051a
Bisphosphonates that are taken only intravenously 4 (8.3%) 5 (8.5%) χ² = 0.001, P = 0.979a
Bisphosphonates that are taken orally and intravenously 39 (81.3%) 49 (83.1%) χ² = 0.059, P = 0.808
One of the main properties of bisphosphonates is the activation of bone resorption 21 (43.8%) 15 (25.4%) χ² = 3.982, P = 0.046
One of the main properties of bisphosphonates is the inhibition of bone resorption 25 (52.1%) 40 (67.8%) χ² = 2.741, P = 0.098
Oral bisphosphonates are absorbed better than intravenous ones 9 (18.8%) 10 (16.9%) χ² = 0.059, P = 0.808
Absorption of intravenous bisphosphonates is better compared to oral bisphosphonates 31 (64.6%) 37 (62.7%) χ² = 0.04, P = 0.841
Sources of knowledge about bisphosphonates
Scientific literature 4 (8.3%) 11 (18.6%) Cramér's
V = 0.316,
P = 0.013
Material provided by professors 9 (18.8%) 21 (35.6%)
Additional sources 0 (0%) 2 (3.4%)
Do not know enough about bisphosphonates 35 (72.9%) 25 (42.4%)
Who can perform tooth extraction for patients taking bisphosphonates
Only a general dentist 1 (2.1%) 4 (6.8%) Cramér's
V = 0.395,
P < 0.001
Only a dentist specialist 31 (64.6%) 15 (25.4%)
Both 16 (33.3%) 40 (67.8%)

aFisher's exact.
n = number.